Effect of CYP4F2 Polymorphisms on Ticagrelor Pharmacokinetics in Healthy Chinese Volunteers

Background: Ticagrelor belongs to a new class of P2Y(12) receptor inhibitor that has been widely used for antiplatelet therapy. This study aimed to explore the effect of single nucleotide polymorphisms (SNPs) in metabolic enzymes, transporters, and other relevant variants on the pharmacokinetics (PK...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Shanshan, Chen, Kaifeng, Guo, Chengxian, Pei, Qi, Zou, Chan, Yao, Liangyuan, Yuan, Hongbo, Zhao, Xia, Xie, Ran, He, Xu, Huang, Jie, Yang, Guoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915292/
https://www.ncbi.nlm.nih.gov/pubmed/35280252
http://dx.doi.org/10.3389/fphar.2021.797278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915292/
https://www.ncbi.nlm.nih.gov/pubmed/35280252
http://dx.doi.org/10.3389/fphar.2021.797278

Ejemplares similares